Sign In

Senthil Krishnaswamy

Scientist I at Abbott

Senthil Krishnaswamy is an innovative and adaptive Biochemist and Molecular Biologist with a strong focus on research in Alzheimer's disease (AD) and fungal disease.

With 10 years of research experience, Senthil has a proven track record of 13 peer-reviewed publications and has completed a New Investigator Research Grant in 2015.

His expertise lies in Drug discovery, particularly in the generation, development, and purification of Monoclonal antibody/Recombinant anti-idiotypic scFv antibody by antibody engineering for therapeutic use.

Having 5 years of experience in the pharmaceutical industry, Senthil specializes in Formulation and Research Development of sustained and conventional release solid orals dosage forms, process optimization, scale-up, exhibit batches, and USFDA dossier submissions.

His primary skills include Monoclonal Antibody generation and development, Antibody Engineering, Phage display and Panning, Octet and Biacore analysis, Protein purification, Confocal Microscopy, and various Molecular biology techniques.

Senthil holds a Master of Pharmacy in Pharmaceutics, a Bachelor of Pharmacy, and a PhD in Biochemistry and Molecular Biology from prestigious institutions.

With a career spanning across organizations like Astellas Pharma US, Abbott, National Institute of Health, NYU LANGONE MEDICAL CENTER, Orchid Pharma, SPIC Pharmaceuticals, The Madras Pharmaceuticals, and MEDOPHARM, Senthil Krishnaswamy has showcased his expertise and dedication in the field of biochemistry and molecular biology.

Senthil Krishnaswamy
Add to my network

Location

United States